169 related articles for article (PubMed ID: 38700521)
1. How Should We Manage Antimicrobial Resistance in Resource-Limited Settings?
Gulleen EA; Lubwama M
AMA J Ethics; 2024 May; 26(5):E373-379. PubMed ID: 38700521
[TBL] [Abstract][Full Text] [Related]
2. The Challenge and Opportunity of Pediatric Antimicrobial Stewardship in Low Resource Settings.
Iroh Tam PY
J Trop Pediatr; 2020 Feb; 66(1):1-3. PubMed ID: 31800059
[No Abstract] [Full Text] [Related]
3. Hospital-Based Antimicrobial Stewardship Programs Used in Low- and Middle-Income Countries: A Scoping Review.
Setiawan E; Abdul-Aziz MH; Roberts JA; Cotta MO
Microb Drug Resist; 2022 May; 28(5):566-584. PubMed ID: 35333607
[TBL] [Abstract][Full Text] [Related]
4. Access to effective antimicrobials: a worldwide challenge.
Laxminarayan R; Matsoso P; Pant S; Brower C; Røttingen JA; Klugman K; Davies S
Lancet; 2016 Jan; 387(10014):168-75. PubMed ID: 26603918
[TBL] [Abstract][Full Text] [Related]
5. Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.
MohanaSundaram A; Sathanantham ST; Sah R; Apostolopoulos V
Maturitas; 2023 Apr; 170():74-75. PubMed ID: 36494242
[No Abstract] [Full Text] [Related]
6. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries.
Mendelson M; Røttingen JA; Gopinathan U; Hamer DH; Wertheim H; Basnyat B; Butler C; Tomson G; Balasegaram M
Lancet; 2016 Jan; 387(10014):188-98. PubMed ID: 26603919
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-Resistant Infections in the Developing World.
Singh P; Holmen J
Pediatr Clin North Am; 2022 Feb; 69(1):141-152. PubMed ID: 34794671
[TBL] [Abstract][Full Text] [Related]
8. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
Thomson KM; Dyer C; Liu F; Sands K; Portal E; Carvalho MJ; Barrell M; Boostrom I; Dunachie S; Farzana R; Ferreira A; Frayne F; Hassan B; Jones E; Jones L; Mathias J; Milton R; Rees J; Chan GJ; Bekele D; Mahlet A; Basu S; Nandy RK; Saha B; Iregbu K; Modibbo F; Uwaezuoke S; Zahra R; Shirazi H; Syed NU; Mazarati JB; Rucogoza A; Gaju L; Mehtar S; Bulabula ANH; Whitelaw A; van Hasselt JGC; Walsh TR;
Lancet Infect Dis; 2021 Dec; 21(12):1677-1688. PubMed ID: 34384533
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?
Bebell LM; Muiru AN
Glob Heart; 2014 Sep; 9(3):347-58. PubMed ID: 25667187
[TBL] [Abstract][Full Text] [Related]
10. Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement.
Berman D; Chandy SJ; Cansdell O; Moodley K; Veeraraghavan B; Essack SY
Lancet Glob Health; 2022 Feb; 10(2):e293-e297. PubMed ID: 34914900
[TBL] [Abstract][Full Text] [Related]
11. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.
Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J
Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481
[TBL] [Abstract][Full Text] [Related]
12. Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship.
Bouza E; Muñoz P; Burillo A
Med Clin North Am; 2018 Sep; 102(5):883-898. PubMed ID: 30126578
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P
Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.
Diazgranados CA; Cardo DM; McGowan JE
Int J Antimicrob Agents; 2008 Jul; 32(1):1-9. PubMed ID: 18550343
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives.
Sirinavin S; Dowell SF
Semin Pediatr Infect Dis; 2004 Apr; 15(2):94-8. PubMed ID: 15185192
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Resistance: a One Health Perspective.
McEwen SA; Collignon PJ
Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29600770
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Stewardship Programs in Resource Constrained Environments: Understanding and Addressing the Need of the Systems.
Kakkar AK; Shafiq N; Singh G; Ray P; Gautam V; Agarwal R; Muralidharan J; Arora P
Front Public Health; 2020; 8():140. PubMed ID: 32411647
[TBL] [Abstract][Full Text] [Related]
18. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.
Godman B; Haque M; McKimm J; Abu Bakar M; Sneddon J; Wale J; Campbell S; Martin AP; Hoxha I; Abilova V; Anand Paramadhas BD; Mpinda-Joseph P; Matome M; de Lemos LLP; Sefah I; Kurdi A; Opanga S; Jakupi A; Saleem Z; Hassali MA; Kibuule D; Fadare J; Bochenek T; Rothe C; Furst J; Markovic-Pekovic V; Bojanić L; Schellack N; Meyer JC; Matsebula Z; Phuong TNT; Thanh BN; Jan S; Kalungia A; Mtapuri-Zinyowera S; Sartelli M; Hill R
Curr Med Res Opin; 2020 Feb; 36(2):301-327. PubMed ID: 31794332
[No Abstract] [Full Text] [Related]
19. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future.
Schultz MJ; Dunser MW; Dondorp AM; Adhikari NK; Iyer S; Kwizera A; Lubell Y; Papali A; Pisani L; Riviello BD; Angus DC; Azevedo LC; Baker T; Diaz JV; Festic E; Haniffa R; Jawa R; Jacob ST; Kissoon N; Lodha R; Martin-Loeches I; Lundeg G; Misango D; Mer M; Mohanty S; Murthy S; Musa N; Nakibuuka J; Serpa Neto A; Nguyen Thi Hoang M; Nguyen Thien B; Pattnaik R; Phua J; Preller J; Povoa P; Ranjit S; Talmor D; Thevanayagam J; Thwaites CL;
Intensive Care Med; 2017 May; 43(5):612-624. PubMed ID: 28349179
[TBL] [Abstract][Full Text] [Related]
20. Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections.
Williams E; Fairley CK; Williamson D
Curr Opin Infect Dis; 2021 Dec; 34(6):591-598. PubMed ID: 34545855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
